Unexpected outcomes? Two case studies of difficult-to-treat gram-negative infections

Prescribing Information for QUOFENIX^®(delafloxacin), VABOREM^®(meropenem/vaborbactam) and TENKASI^® (oritavancin) can be found below under Useful Resources

Unexpected outcomes? Two case studies of difficult-to-treat gram-negative infections

Presented by: Dr Kavita Singh, Consultant Microbiologist and lead technician at Leeds teaching Hospital.
Professor Ignacio Martin-Loechesis, Consultant in Intensive Care Medicine at St James’s Hospital and Professor at Trinity College, Dublin, Ireland.

Content summary: Presentations on two clinical case studies from the UK and Ireland in the use of VABOREM®(meropenem/vaborbactam).

Useful Resources

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to A. Menarini Farmaceutica Internazionale SRL. Phone 0800 085 8678 or email: [email protected]

These medicinal products are subject to additional monitoring.

Dr Kavita Sethi has been a Consultant Microbiologist at Leeds Teaching Hospitals and Honorary Clinical lecturer at University of Leeds since 2004. She is now the Lead clinician in Microbiology since Jan 2020. Her specialist areas of interest include antimicrobial stewardship, catheter related bloodstream infections and paediatric sepsis. The landscape of hospital infections is changing and challenging and Kavita has used her scientific knowledge and experience to deal with difficult to treat infections in vulnerable patient groups.

Ignacio Martin-Loeches, MD, PhD, FJFICMI is a full-time Consultant in Intensive Care Medicine at St James’s Hospital and Professor at Trinity College, Dublin, Ireland. He was the Chair of CoBaTrICE (International Competency Based Training programme in Intensive Care Medicine for Europe and other world regions) under the European Society of Intensive Care Medicine (ESICM) and past-elected council member of the World Federation of Societies of Intensive and Critical Care Medicine. He is part of the Steering committee and executive member of the research-working group of the Surviving Sepsis Campaign (SSC). He is the current elected Chair of the Acute Critical Care Group at the European Respiratory Society (ERS).

PP-AI-UK-0485 April 2024